Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

Absztrakt
Leírás
Kulcsszavak
Forrás
RMD Open. -8 : 2 (2022), p. 1-10. -RMD Open. - 2056-5933